Literature DB >> 9295043

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.

M Benkerrou1, F Le Deist, J P de Villartay, S Caillat-Zucman, F Rieux-Laucat, N Jabado, M Cavazzana-Calvo, A Fischer.   

Abstract

Recently, an inherited syndrome characterized by nonmalignant lymphoproliferation with autoimmune manifestations, caused by mutations of the Fas (CD95) receptor gene has been described. Because of disease severity, i.e. unremitting lymphoproliferation in a child with complete Fas deficiency, a haploidentical bone marrow transplantation (BMT) was performed despite the known resistance of Fas-deficient lpr mice to bone marrow transplantation. Marrow graft was rejected early; however, a second attempt using bone marrow from the mother led to engraftment and to control of lymphoproliferation and of autoimmune thrombocytopenia up to the last follow-up at 24 months after BMT. This single case shows that resistance to bone marrow engraftment caused by survival of Fas-deficient cells can be overcome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295043     DOI: 10.1002/eji.1830270831

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  How I treat autoimmune lymphoproliferative syndrome.

Authors:  V Koneti Rao; João Bosco Oliveira
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

Review 2.  Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?

Authors:  J P de Villartay; F Rieux-Laucat; A Fischer; F Le Deist
Journal:  Springer Semin Immunopathol       Date:  1998

3.  p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus.

Authors:  César Muñoz-Fontela; Michael Pazos; Igotz Delgado; William Murk; Sathish Kumar Mungamuri; Sam W Lee; Adolfo García-Sastre; Thomas M Moran; Stuart A Aaronson
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

Review 4.  The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.

Authors:  Frédéric Rieux-Laucat; Aude Magérus-Chatinet; Bénédicte Neven
Journal:  J Clin Immunol       Date:  2018-06-17       Impact factor: 8.317

Review 5.  A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.

Authors:  T A Fleisher; S E Straus; J J Bleesing
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 6.  Autoimmune lymphoproliferative syndrome: etiology, diagnosis, and management.

Authors:  Jutte van der Werff ten Bosch
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 7.  Autoimmune lymphoproliferative syndrome: an update and review of the literature.

Authors:  Shaili Shah; Eveline Wu; V Koneti Rao; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2014-09       Impact factor: 4.806

Review 8.  Genetic defects of apoptosis and primary immunodeficiency.

Authors:  Helen C Su; Michael J Lenardo
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

Review 9.  ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.

Authors:  Filippo Consonni; Eleonora Gambineri; Claudio Favre
Journal:  Ann Hematol       Date:  2022-01-20       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.